Medicare Drug Plans: Restrictions on Access to Formulary Drugs

Thumbnail Image
Serial Number
Levin Center Identifier
Document Date
Report Length
12 pages
Policy Agendas Project Major Code
Policy Agendas Project Minor Code
Additional, Minority, Dissenting Views
Found Using Methodology
Idependent Author(s)
Brief Executive Summary
The Special Investigations Division of the House Committee on Government Reform examined tactics used by Medicare drug plans that limit access to prescription drugs on plan formularies. The analysis is based on a Medicare database, a phone survey of Medicare drug plans, and information available online. The findings reveal widespread use of restrictive tactics by Medicare drug plans, such as prior authorization, step therapy, and volume limits.
Related Hearings
Authors–Congress Members
Authors–Staff Members
Authors–Ex Officio Members
Authors–Additional, Minority, Dissenting Views